Literature DB >> 11151059

Hereditary cancer syndromes.

T S Frank1.   

Abstract

OBJECTIVE: To summarize the biological basis, clinical implications, identification, and medical management of syndromes associated with increased risk of common adult cancers. DATA SOURCES: Recent studies and data available from molecular and clinical analysis of genes responsible for autosomal-dominant inheritance of cancer risk. DATA SYNTHESIS: Several hereditary cancer syndromes have been identified for which there are increasingly effective diagnostic and management options. Specific hereditary susceptibility syndromes have been characterized that increase the risk of malignancies of the breast, ovary, colon, endometrium, and endocrine organs. Following a summary of the biological basis of hereditary cancer risk in adults, the identification of such syndromes by clinical and laboratory means is reviewed. Finally, management options for individuals with these syndromes are summarized.
CONCLUSIONS: Advances in gene discovery have allowed the diagnosis of recently characterized hereditary cancer syndromes to enhance medical management for individuals with inherited susceptibility to common cancers.

Entities:  

Mesh:

Year:  2001        PMID: 11151059     DOI: 10.5858/2001-125-0085-HCS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Risk of second primary cancer in men with breast cancer.

Authors:  Sacha Satram-Hoang; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

Review 2.  Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Authors:  Shengming Zhu; Jiangang Wang; Lucas Zellmer; Ningzhi Xu; Mei Liu; Yun Hu; Hong Ma; Fei Deng; Wenxiu Yang; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

3.  Analysis on the clinical and pathological features and prognosis of familial gastric cancer in South china population: a single-center study of 724 patients.

Authors:  Jun Lu; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin
Journal:  J Oncol       Date:  2012-11-07       Impact factor: 4.375

4.  Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?

Authors:  Brent D Kerger; Robert C James; David A Galbraith
Journal:  Front Genet       Date:  2014-05-30       Impact factor: 4.599

Review 5.  The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.

Authors:  F Blok; E M Roes; G J L H van Leenders; H J van Beekhuizen
Journal:  BMC Cancer       Date:  2016-01-14       Impact factor: 4.430

6.  Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.

Authors:  Lenny N Gallardo-Alvarado; María Teresa Tusié-Luna; María Isabel Tussié-Luna; José Díaz-Chávez; Yayoi X Segura; Enrique Bargallo-Rocha; Cynthia Villarreal; Luis A Herrera-Montalvo; Enrique M Herrera-Medina; David F Cantu-de Leon
Journal:  BMC Cancer       Date:  2019-02-01       Impact factor: 4.430

7.  A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.

Authors:  Laura Cortesi; Bruna Baldassarri; Stefano Ferretti; Elisabetta Razzaboni; Mariangela Bella; Lauro Bucchi; Debora Canuti; Pierandrea De Iaco; Giorgio De Santis; Fabio Falcini; Vania Galli; Lea Godino; Maurizio Leoni; Anna Myriam Perrone; Marco Pignatti; Gianni Saguatti; Donatella Santini; Priscilla Sassoli de'Bianchi; Federica Sebastiani; Mario Taffurelli; Giovanni Tazzioli; Daniela Turchetti; Claudio Zamagni; Carlo Naldoni
Journal:  Cancer Med       Date:  2020-02-11       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.